Newly Formed Oligodendrocytes (NFOLs)

Newly Formed Oligodendrocytes

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Newly Formed Oligodendrocytes (NFOLs)</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000816](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000816)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0000816](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000816)</td>
</tr>
</table>

Introduction

Newly Formed Oligodendrocytes (Nfols) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

...

Newly Formed Oligodendrocytes

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Newly Formed Oligodendrocytes (NFOLs)</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000816](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000816)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0000816](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000816)</td>
</tr>
</table>

Introduction

Newly Formed Oligodendrocytes (Nfols) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Newly formed oligodendrocytes (NFOLs) are the immediate progeny of oligodendrocyte precursor cells (OPCs) that have recently committed to the oligodendrocyte lineage and begun the differentiation process. These cells represent a critical transitional stage in the oligodendrocyte developmental continuum, bridging OPCs to mature, myelinating oligodendrocytes["@bergles2015"].

In the context of neurodegeneration, NFOLs play essential roles in remyelination attempts, which occur as a compensatory response to demyelination in diseases such as multiple sclerosis (MS), Alzheimer's disease, Parkinson's disease, and traumatic brain injury. Understanding NFOL biology is crucial for developing therapeutic strategies aimed at enhancing endogenous remyelination["@franklin2008"].

<!-- taxonomy-enrichment -->

<!-- multi-taxonomy-enrichment -->

Multi-Taxonomy Classification

Taxonomy Database Cross-References

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• [Cell Ontology (CL:0000816)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000816)
• [OBO Foundry (CL:0000816)](http://purl.obolibrary.org/obo/CL_0000816)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [Human Cell Atlas](https://www.humancellatlas.org/)
• [PanglaoDB](https://panglaodb.se/)

Taxonomy & Classification

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• [Cell Ontology (CL:0000816)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000816)
• [OBO Foundry (CL:0000816)](http://purl.obolibrary.org/obo/CL_0000816)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [PanglaoDB](https://panglaodb.se/)

Development and Differentiation

Lineage Progression

The oligodendrocyte lineage proceeds through distinct stages:

OPC (Oligodendrocyte Precursor Cell): Proliferative, migratory progenitors expressing PDGFRα, NG2, and Olig2

NFOL (Newly Formed Oligodendrocyte): Post-mitotic, early differentiating cells beginning to express OLIG2, NKX2.2, and MBP

MO (Mature Oligodendrocyte): Fully differentiated, myelinating cells expressing MBP, PLP, and CNP

Transition from OPC to NFOL

Key molecular events during OPC-to-NFOL transition[@zhang2019]:

• Cell cycle exit: PDGF withdrawal and increased cyclin-dependent kinase inhibitor expression
• Transcription factor switch: Sustained Olig2, activation of Sox10, NKX2.2
• Early myelin gene activation: Begin expressing MBP and PLP at low levels
• Morphological changes: Initial process extension, soma compaction

Molecular Characteristics

Surface Markers

NFOLs express a combination of markers:

• Olig2: Master transcription factor (persistently expressed)
• NKX2.2: Homeodomain transcription factor
• Sox10: Sry-related HMG box transcription factor
• MBP: Myelin basic protein (low levels)
• PLP: Proteolipid protein (low levels)
• CNP: 2',3'-Cyclic nucleotide 3'-phosphodiesterase

Metabolic Properties

NFOLs have distinct metabolic features:

• High metabolic demand: Increased mitochondrial activity for myelin synthesis
• Lipid biosynthesis: Active cholesterol and fatty acid synthesis
• Iron metabolism: Critical for oligodendrocyte function and survival

Function in Neural Circuits

Myelin Formation

NFOLs are the cells that will become mature myelinating oligodendrocytes:

• Extend processes toward axons
• Initiate axonal ensheathment
• Begin forming compact myelin sheaths
• Support saltatory conduction

Metabolic Support

Oligodendrocytes provide metabolic support to neurons:

• Lactate shuttling to axons
• Mitochondrial support
• Glucose transport via GLUT1

Role in Neurodegenerative Diseases

Multiple Sclerosis

In MS, NFOLs represent the remyelination response[@chang2000]:

• Remyelination attempts: NFOLs form in lesion borders
• Failure mechanisms: Differentiation block, inflammatory inhibition
• Therapeutic target: Promoting NFOL differentiation
• Remyelination failure: Leads to "shadow plaques"

Alzheimer's Disease

Oligodendrocyte dysfunction in AD includes[@bartzokis2004]:

• White matter abnormalities: Demyelination in AD brains
• NFOL impairment: Reduced oligodendrocyte lineage cells
• Myelin breakdown: Associated with cognitive decline
• Metabolic vulnerability: Oligodendrocytes are metabolically stressed

Parkinson's Disease

In PD, NFOLs and oligodendrocytes are affected:

• Oligodendrocyte loss: Reduced MBP in substantia nigra
• White matter changes: Observed in PD imaging studies
• Demyelination: Contributing to circuit dysfunction
• Therapeutic potential: Enhancing remyelination

Traumatic Brain Injury

NFOLs respond to demyelination after TBI:

• Acute response: OPCs proliferate and differentiate
• Remyelination: NFOLs attempt regeneration
• Incomplete recovery: Often fails to fully remyelinate

Therapeutic Implications

Enhancing NFOL Differentiation

Drug development focuses on[@najm2015]:

• clemastine: Antihistamine promoting OPC differentiation
• miconazole: Antifungal enhancing oligodendrocyte differentiation
• benztropine: Anticholinergic with remyelination potential
• op正中olidar: ROR agonist promoting OPC differentiation

Overcoming Differentiation Block

Strategies include:

• HDAC inhibitors: Reduce inhibitory histone modifications
• Notch signaling antagonists: Block differentiation inhibitors
• cAMP elevation: Promote differentiation pathway
• Growth factor support: BDNF, PDGF delivery

Cell Replacement Therapy

Approaches include:

• OPC transplantation: Direct cell delivery
• iPSC-derived oligodendrocytes: Personalized therapy
• Optimizing engraftment: Improving survival and integration

See Also

• Oligodendrocyte Precursor Cells (OPCs)
• Mature Oligodendrocytes
• Myelin Basic Protein (MBP)
• [Multiple Sclerosis](/diseases/multiple-sclerosis)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Remyelination](/mechanisms/remyelination)

Background

The study of Newly Formed Oligodendrocytes (Nfols) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
• [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
• [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

Research Evidence

Evidence from SEA-AD paper analysis on oligodendrocytes

Finding 1: Supported Causal Chain

Telencephalic OPCs are more proliferative, differentiate more frequently, and form a larger population relative to oligodendrocytes, explaining lower proportion of mature Type 2 oligodendrocytes

Supporting evidence:

• Siletti, Kimberly et al. (2023). Transcriptomic diversity of cell types across the adult human brain. https://doi.org/10.1101/2022.10.12.511898

Finding 2: Supported Mechanistic Proposal

Pick's disease tau exists as distinct conformational strains in different cell types (neurons, astrocytes, oligodendrocytes) within the same brain

Supporting evidence:

• Yang, Hyunjun et al. (2023). EMBER multidimensional spectral microscopy enables quantitative determination of disease- and cell-specific amyloid strains. https://doi.org/10.1073/pnas.2300769120

Finding 3: Speculative Therapeutic Hypothesis

IL-12 (but not IL-23) signaling is the main driver of AD-specific neuroinflammation and alters neuronal and oligodendrocyte functions

Supporting evidence:

• Piwecka, Monika, Rajewsky, Nikolaus, Rybak-Wolf, Agnieszka (2023). Single-cell and spatial transcriptomics: deciphering brain complexity in health and disease. https://doi.org/10.1038/s41582-023-00809-y

References

[67] Piwecka, Monika, Rajewsky, Nikolaus, Rybak-Wolf, Agnieszka (2023). Single-cell and spatial transcriptomics: deciphering brain complexity in health and disease. https://doi.org/10.1038/s41582-023-00809-y

[93] Siletti, Kimberly et al. (2023). Transcriptomic diversity of cell types across the adult human brain. https://doi.org/10.1101/2022.10.12.511898

[101] Yang, Hyunjun et al. (2023). EMBER multidimensional spectral microscopy enables quantitative determination of disease- and cell-specific amyloid strains. https://doi.org/10.1073/pnas.2300769120

Pathway Diagram

The following diagram shows the key molecular relationships involving Newly Formed Oligodendrocytes (NFOLs) discovered through SciDEX knowledge graph analysis: